Fabhalta Cost, Coupons, Copay Card & Savings: The Complete 2026 Guide
Living with a rare blood disorder means fighting for a diagnosis, then fighting for the treatment — and then, too often, fighting the price of it. Whether you’re looking for a Fabhalta coupon, manufacturer coupon, copay card, savings card, the cost without insurance, or how to get Fabhalta at no cost, this guide covers every way to lower the cost of Fabhalta (iptacopan) — and why, for many patients, the Patient Assistance Program through Afford My Prescriptions is the strongest option. Our advocates may be able to get you brand-name Fabhalta at no medication cost.
You May Qualify for Fabhalta at low cost or no cost.
Talk to an Expert & Check Your Eligibility
Find out if you’re eligible for a low cost or no cost brand-name Fabhalta supply. Less than 2 minutes · No fee · No obligation.
(833) 556 2729
How It Works — 3 Simple Steps
Check If You Qualify
Answer a few quick questions online — less than 2 minutes, no fee, no obligation.
Talk to an Advocate
A dedicated patient advocate reviews your situation and options within 24 hours, confidentially.
Get Your Medication
If approved, you receive brand-name Fabhalta through the manufacturer’s program while we handle the paperwork.
Key Takeaways
- Without insurance, Fabhalta costs roughly $46,854 for 60 capsules — about a month at the 200 mg twice-daily dose, or over $560,000 a year. Confirm current pricing with your pharmacy.
- Fabhalta is an oral capsule you take at home and is filled through your pharmacy benefit — which is what makes the 2026 Medicare Part D out-of-pocket cap so consequential here.
- The manufacturer’s copay program lets eligible commercially insured patients pay $0 per prescription, with maximum savings of $20,000 per calendar year plus up to $1,000 toward qualifying vaccination costs — Medicare, Medicaid, and uninsured patients are excluded.
- The manufacturer’s Patient Assistance Program (PAP) covers who the copay program excludes: qualifying patients may receive brand-name Fabhalta at no medication cost, shipped directly to them. We handle the entire process for a flat $69.95/month.
What This Guide Covers
The Fabhalta Coupon, Copay Card & Savings Card: What It Is & Who Qualifies
The manufacturer’s savings program (searched as the “Fabhalta coupon,” “Fabhalta manufacturer coupon,” “copay card,” or “savings card”) lets eligible commercially insured patients pay $0 per prescription, with maximum savings of $20,000 per calendar year, plus up to $1,000 per calendar year toward qualifying vaccination costs (administrative fees excluded). That vaccination benefit matters more than it might sound — vaccination is a requirement before starting this class of medication, and those costs are real.
There’s also a bridge offer: eligible commercially insured patients may receive up to 12 months of free medication while coverage is being determined. That’s an unusually generous stopgap for a rare-disease therapy — but read what it is: a bridge for people who have commercial insurance and are waiting on a decision. It’s not a destination.
The catch: everything above requires commercial (private) insurance. Medicare, Medicaid, TRICARE, and uninsured patients are excluded by federal law and program terms alike. If that’s your situation, the manufacturer’s Patient Assistance Program exists precisely for you — and our advocates handle the entire application, confidentially.
The Fabhalta Savings Program In 4 Quick Facts
- What it does: eligible patients pay $0 per prescription.
- The limits: maximum savings of $20,000 per calendar year, plus up to $1,000 toward qualifying vaccination costs.
- If coverage is pending: a bridge offer may provide up to 12 months of free medication while a decision is made.
- Who it excludes: Medicare, Medicaid, other government plans, and the uninsured. For all of them, the Patient Assistance Program is the path that actually works.
Fabhalta Cost & Cost Without Insurance
| Product & strength | Cash price (approx.) | With our PAP advocacy |
|---|---|---|
| Fabhalta 200 mg oral capsule — 60 capsules (about a month at 200 mg twice daily) | from ~$46,853.75 (about $781 per capsule) | $69.95/month flat — brand-name medication at no additional cost if you qualify for the manufacturer’s PAP |
| Annualized at the twice-daily maintenance dose | over $560,000 per year |
Prices are estimates for cash-paying customers based on public data (mid-2026) and vary by pharmacy and location — confirm current pricing with your pharmacy. Your prescriber sets your dose. These figures cover the medication only and don’t include the vaccinations, monitoring, or lab work that go with this therapy.
Why Is Fabhalta So Expensive?
Fabhalta treats paroxysmal nocturnal hemoglobinuria and other rare complement-driven conditions — diseases that affect a very small number of people. That’s the core of the arithmetic: the cost of discovering, trialing, and manufacturing a targeted complement inhibitor is spread across a patient population measured in thousands, not millions. It’s patented and protected from price competition, it requires a controlled distribution program with enrolled prescribers and pharmacies, and it sits on the highest specialty tier every insurer maintains. And it’s not a course of treatment — it’s a daily, ongoing therapy, so the price recurs every month for as long as you need it. For a medication that stands between you and the hemolysis that defines your disease, that pricing model is exactly why the Patient Assistance Program — the medication itself at no cost for qualifying patients — matters more than any coupon.
PATIENT ASSISTANCE PROGRAM
Facing $46,000 a month for a rare disease medication? You may not have to.
How To Get Fabhalta For Free: The Honest Answer
If you’re searching “how to get Fabhalta for free,” here’s the truthful version: for commercially insured patients whose plan covers it, the manufacturer’s copay program already brings the cost to $0 per prescription, up to the annual cap — and if coverage is still pending, the bridge offer may supply up to 12 months at no cost while that’s sorted out. For everyone else — uninsured, underinsured, or on Medicare — the only genuine no-cost route is the manufacturer’s Patient Assistance Program, which supplies brand-name Fabhalta at no medication cost to qualifying patients based on income, shipped directly to you. Eligibility is reviewed case-by-case against the federal poverty level, and with a medication priced above half a million dollars a year, “underinsured” describes far more people than you’d think — including plenty with insurance and steady jobs. It isn’t a trick or a loophole; it’s a real program with real paperwork — income documentation, prescriber forms, renewals — and that paperwork is exactly what our advocates take off your plate for a flat monthly fee.
A Note On Enrollment & Vaccination Requirements
Fabhalta is distributed under a Risk Evaluation and Mitigation Strategy (REMS) — a safety program the FDA requires for this class of medication. In practice, that means your prescriber, your healthcare facility, your pharmacy, and you as the patient must all be enrolled before treatment starts. It also means vaccination is required beforehand: because Fabhalta works by inhibiting part of your complement system, it raises the risk of serious infections from encapsulated bacteria, and vaccination is how that risk is managed. None of this is optional, and none of it is something to work around — your care team will walk you through the requirements and timing. We flag it here for one reason: these steps take time and can carry their own costs, and patients are sometimes blindsided by them at the worst moment. Our advocates factor the enrollment timeline into the assistance paperwork so that access and readiness line up rather than collide.
What To Do If The Fabhalta Savings Program Doesn’t Cover You
Reasons You May Be Facing Huge Bills
- You’re uninsured. The copay program requires commercial insurance.
- You’re on Medicare or Medicaid. Federal law prohibits manufacturer copay programs with government plans.
- The $20,000 annual cap ran out — against a six-figure annual price, it can.
- Your plan denied Fabhalta or requires prior authorization your specialist is still fighting.
- You’re between coverage — a job change or plan switch mid-treatment, with a rare-disease medication you cannot simply pause.
If any of these describe you, the strongest next step is the manufacturer’s Patient Assistance Program: brand-name Fabhalta at no medication cost for qualifying patients, reviewed case-by-case on income, shipped directly to you. Being denied or priced out is often exactly what qualifies you. And with a complement inhibitor, continuity isn’t a preference — it’s clinical. Interrupting treatment can allow hemolysis to return, sometimes abruptly, which is why your care team monitors closely if therapy is ever stopped. A lapse driven by paperwork or price is the kind of gap that should never happen. Our advocates confirm eligibility, submit the application, coordinate with your prescriber, and manage refills and yearly re-certification — with continuity of treatment as the first priority.
YOU HAVE OPTIONS
Denied, On Medicare, Or Uninsured? There’s A Path.
Talk to a patient advocate about the Patient Assistance Program through Afford My Prescriptions. No fee for the eligibility check. No obligation. Completely confidential.
Fabhalta Coupons Vs. The Patient Assistance Program
Limitations Of Coupons
- Commercial insurance required — Medicare/Medicaid excluded
- $20,000/year cap — meaningful, but small against the annual price
- The bridge offer is temporary, for patients awaiting a coverage decision
- Stops working the day your insurance changes or you retire onto Medicare
- Terms change or end without notice — confirm current terms
Advantages Of PAP Through Us
- Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
- Medication shipped directly from the manufacturer’s program
- We manage all paperwork, refills, and renewals — confidentially
- If denied, we explore alternative savings paths on your behalf
The Cheapest Way To Get Fabhalta (By Situation)
| Your situation | Cheapest realistic option |
|---|---|
| Commercial insurance that covers Fabhalta | Manufacturer copay program — $0 per prescription (up to $20,000/year, plus vaccination support) |
| Commercial insurance, coverage decision pending | Bridge offer (up to 12 months free), then PAP through Afford My Prescriptions if coverage falls through |
| Uninsured | Patient Assistance Program through Afford My Prescriptions — no medication cost if eligible |
| Medicare / Part D | Patient Assistance Program through Afford My Prescriptions (copay programs are not allowed on Medicare); the 2026 Part D cap limits the rest |
| Medicaid | State coverage often applies to rare-disease therapies with prior authorization; if not, ask an advocate |
Does Medicare Cover Fabhalta?
Yes — because Fabhalta is an oral capsule you take at home and fill at a pharmacy, it’s covered under Medicare Part D, your prescription benefit. For a medication priced above half a million dollars a year, that distinction is worth more than almost anything else on this page: the 2026 Part D out-of-pocket cap of $2,100 per year applies, and once you reach it — which, at this price, happens with your first fill — your covered Part D drug costs are finished for the calendar year. You can also spread that $2,100 across the year through the monthly payment option rather than absorbing it in January, and the Extra Help subsidy can reduce it further for those with limited income. What Medicare patients cannot use is the manufacturer’s copay program — federal law prohibits it. But Medicare patients may qualify for the manufacturer’s Patient Assistance Program based on income, reviewed case-by-case, and independent charitable foundations sometimes have funds open for rare-disease diagnoses. Our advocates check every path and handle the paperwork.
Our Pricing: One Flat Monthly Fee, No Surprises
| Medications enrolled | Flat monthly fee |
|---|---|
| 1 medication | $69.95/month |
| 2 medications | $79.95/month |
| 3 medications | $89.95/month |
| 4+ medications | $99.95/month |
The fee covers our advocacy service: eligibility confirmation, PAP application preparation and submission, prescriber coordination, refill management, and annual re-certification. If you qualify, the medication itself comes from the manufacturer’s program at no medication cost. Many people managing a rare blood disorder also take supportive medications — one flat fee can cover PAP applications for all of them.
How It Works — 3 Simple Steps
- 1. Check if you qualify — answer a few quick questions online. Less than 2 minutes, no fee, no obligation.
- 2. Talk to an advocate — a dedicated patient advocate reviews your situation and options within 24 hours, confidentially.
- 3. Get your medication — if approved, you receive brand-name Fabhalta through the manufacturer’s program while we handle the paperwork.
Fabhalta Patient Assistance: Eligibility & How To Apply
- You are a U.S. citizen or legal resident living in the U.S. or a U.S. territory, treated by a U.S.-licensed provider
- You have a valid Fabhalta prescription for an FDA-approved diagnosis, with the required safety-program enrollment in place
- You are uninsured or underinsured (Medicare situations reviewed case-by-case)
- Your household income meets the program criteria, based on the federal poverty level — eligibility is determined case-by-case, and at this price point patients who assume they earn too much routinely qualify
What Is Fabhalta & How Does It Work?
Fabhalta (iptacopan) is a prescription oral capsule — a targeted complement inhibitor, taken 200 mg twice daily. It works by blocking Factor B in the alternative complement pathway, the part of your immune system that, in paroxysmal nocturnal hemoglobinuria (PNH), destroys your own red blood cells. It’s also used in certain rare kidney conditions, including C3 glomerulopathy and IgA nephropathy. Because it dampens complement activity, it carries a serious infection risk that’s managed through required vaccination and a controlled distribution program — steps your care team handles before you start. Taking it consistently is the entire point: this is a daily therapy that holds hemolysis in check, and lapses can let disease activity return. That’s why uninterrupted, predictable affordability isn’t a nice-to-have; it’s part of the treatment plan. That’s the problem the Patient Assistance Program solves for qualifying patients.
Fabhalta Cost & Savings FAQ
Is there a Fabhalta manufacturer coupon?
Yes. The manufacturer’s copay program lets eligible commercially insured patients pay $0 per prescription, with maximum savings of $20,000 per calendar year plus up to $1,000 toward qualifying vaccination costs (administrative fees excluded). A separate bridge offer may provide up to 12 months of free medication while a coverage decision is pending. Confirm current terms. None of it is valid for Medicare, Medicaid, or uninsured patients — for them, the Patient Assistance Program through Afford My Prescriptions is the stronger option.
How much does Fabhalta cost without insurance?
Roughly $46,854 for 60 capsules — about a month at the 200 mg twice-daily dose, or over $560,000 a year, which works out to about $781 per capsule. Prices vary by pharmacy and location, so confirm current pricing. Before facing a bill like that, check your Patient Assistance Program eligibility: qualifying patients receive brand-name Fabhalta at no medication cost.
How do I get Fabhalta for free?
Qualifying uninsured, underinsured, and Medicare patients may receive brand-name Fabhalta at no medication cost through the manufacturer’s Patient Assistance Program, with medication shipped directly to them. Eligibility is based on the federal poverty level and reviewed case-by-case. Our advocates verify eligibility, submit the application, and manage refills and renewals for a flat $69.95/month — confidentially.
Does Medicare cover Fabhalta, and does the $2,100 cap apply?
Yes to both. Fabhalta is an oral medication filled at a pharmacy, so it falls under Part D — meaning the 2026 Part D out-of-pocket cap of $2,100 per year applies, and at this price you’ll reach it immediately and then owe nothing more for covered Part D drugs that year. The monthly payment option can spread that $2,100 across the year, and Extra Help lowers it further for lower incomes. Medicare patients can’t use the manufacturer’s copay program, but many qualify for the Patient Assistance Program based on income. Our advocates check every path.
Is there a generic version of Fabhalta?
No. Fabhalta (iptacopan) is available as a brand-name drug only, and a generic version is not yet available — confirm current availability with your care team, since whether any alternative is appropriate is a decision for your prescriber and your plan, never something to change on your own. With no cheaper version to switch to, the Patient Assistance Program is the main way patients who can’t use the copay program make Fabhalta affordable.
My insurance denied Fabhalta. What now?
Denials are common for rare-disease therapies at this price, and they’re often exactly what qualifies you for help. Your specialist can appeal with clinical documentation, the bridge offer may cover commercially insured patients while a decision is pending, and patients who are denied, uninsured, underinsured, or on Medicare may qualify to receive brand-name Fabhalta at no medication cost through the Patient Assistance Program through Afford My Prescriptions while we manage the entire process. Don’t let doses lapse while paperwork moves — talk to your care team about any interruption, and start with a 2-minute eligibility check.